lupron depot Drug Patent Profile
✉ Email this page to a colleague
When do Lupron Depot patents expire, and when can generic versions of Lupron Depot launch?
Lupron Depot is a drug marketed by Abbvie Endocrine Inc and is included in five NDAs. There are two patents protecting this drug.
This drug has thirty-five patent family members in twenty-eight countries.
The generic ingredient in LUPRON DEPOT is leuprolide acetate. There are twenty-two drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the leuprolide acetate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Lupron Depot
A generic version of lupron depot was approved as leuprolide acetate by SANDOZ on August 4th, 1998.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for lupron depot?
- What are the global sales for lupron depot?
- What is Average Wholesale Price for lupron depot?
Summary for lupron depot
International Patents: | 35 |
US Patents: | 1 |
Applicants: | 1 |
NDAs: | 5 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Clinical Trials: | 133 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for lupron depot |
What excipients (inactive ingredients) are in lupron depot? | lupron depot excipients list |
DailyMed Link: | lupron depot at DailyMed |
![lupron depot drug patent expirations Drug patent expirations by year for lupron depot](/p/graph/s/t/lupron_depot-patent-expirations.png)
![Drug Prices for lupron depot](/p/graph/drug-price/lupron+depot.png)
Recent Clinical Trials for lupron depot
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prostate Cancer Foundation | Phase 2 |
Panbela Therapeutics | Phase 2 |
National Cancer Institute (NCI) | Phase 4 |
US Patents and Regulatory Information for lupron depot
lupron depot is protected by one US patents.
Patents protecting lupron depot
Sustained-release composition and method for producing the same
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: PALLIATIVE TREATMENT OF PROSTATE CANCER
Expired US Patents for lupron depot
International Patents for lupron depot
See the table below for patents covering lupron depot around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 0172636 | METHOD FOR PRODUCING A POLYMER OR COPOLYMER OF LACTIC ACID AND/OR GLYCOLIC ACID | ⤷ Sign Up |
Ukraine | 97125 | КОМПОЗИЦИЯ ПРОДОЛЖИТЕЛЬНОГО ВЫСВОБОЖДЕНИЯ И СПОСОБ ЕЕ ПОЛУЧЕНИЯ;КОМПОЗИЦІЯ ТРИВАЛОГО ВИВІЛЬНЕННЯ І СПОСІБ ЇЇ ОДЕРЖАННЯ (SUSTAINED-RELEASE COMPOSITION AND METHOD FOR PRODUCING THE SAME) | ⤷ Sign Up |
Denmark | 1330293 | ⤷ Sign Up | |
Brazil | PI0210561 | composição de liberação controlada compreendendo polímero de ácido lático e um derivado de lh-rh, método de produção da mesma, e, medicamento. | ⤷ Sign Up |
China | 1292796 | ⤷ Sign Up | |
Austria | 42197 | ⤷ Sign Up | |
European Patent Office | 1491236 | Composition pharmacéutique orale à libération controlée contenant des polymères d'acide lactique, de l'acide hydroxynaphtoique, et son procédé de préparation (Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same) | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |